Skip to main content

Table 1 Characteristics between young TBM patients in stroke group and non-stroke group

From: Acute ischemic stroke in young adults with tuberculous meningitis

 

Total (n = 52)

Stroke group (n = 12)

Non-stroke group (n = 40)

p value

Age (years)

30.3 ± 9.9

35.9 ± 10.8

28.4 ± 9.3

0.040

Sex (male, %)

33 (63.5%)

8 (66.7%)

25 (62.5%)

1.000

Smoking, %

11 (21.2%)

2 (25.0%)

9 (22.5%)

1.000

HIV, %

3 (5.8%)

2 (16.7%)

1 (2.5%)

0.254

Clinical presentations

 Fever, %

44 (84.6%)

10 (83.3%)

34 (85.0%)

1.000

 Headache, %

39 (75.0%)

12 (100%)

27 (67.5%)

0.024

 Vomiting, %

17 (32.7%)

5 (41.7%)

12 (30.0%)

0.686

 Altered consciousness, %

17 (32.7%)

5 (41.7%)

12 (30.0%)

0.686

 Visual disturbance, %

6 (11.5%)

2 (16.7%)

4 (10.0%)

0.905

 Cranial nerve palsy, %

8 (15.4%)

4 (33.3%)

4 (10.0%)

0.131

 Focal weakness, %

12 (23.1%)

5 (41.7%)

7 (17.5%)

0.176

 Neck stiffness, %

21 (40.4%)

7 (58.3%)

14 (35.0%)

0.267

 Seizure, %

8 (15.4%)

2 (16.7%)

6 (15.5%)

1.000

GCS score

 3–10

7 (13.5%)

4 (33.3%)

3 (7.5%)

 

 11–15

45 (86.5%)

8 (66.7%)

37 (92.5%)

0.069

Stage of TBM

 Stage I

36 (69.2%)

7 (58.3%)

29 (72.5%)

 

 Stage II

9 (17.3%)

1 (8.3%)

8 (20.0%)

 

 Stage III

7 (13.5%)

4 (33.4%)

3 (7.5%)

0.195

Clinical outcome

Good outcome (mRS = 0)

35 (67.3%)

5 (41.7%)

30 (75.0%)

 

Intermediate outcome (mRS 1–2)

9 (17.3%)

3 (25.0%)

6 (12.5%)

 

Poor outcome (mRS 3–5 and death)

8 (15.4%)

4 (33.3%)

4 (10.0%)

0.024

  1. TBM indicates tuberculous meningitis; HIV indicates human immunodeficiency virus; GCS indicates Glasgow Coma Scale; mRS indicates Modified Rankin Scale